Skip to content

PHARMADIX

Active
Private limited companyfounded 2022active for 3 yearsKorteweg 5, 8560 Wevelgem, BelgiumKBO/BCE: BE 0794.868.478

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
22-06
NBB filing Annual accounts 2025 filedNBB
micro format · 39 days before the deadline
2025
31-12
Financial Liquidity more than doubledcurrent ratio 10.34
The current ratio rises from 3.91 to 10.34. Short-term debt falls from €45,581 to €21,002.
31-12
Financial Equity above €200,000equity €203,726 ▲44.1%
With a profit in every financial year since 2023, equity grows to €203,726.
27-06
NBB filing Annual accounts 2024 filedPDF
micro format · 34 days before the deadline
2024
31-12
Financial Weakest financial yearnet €38,317 ▼58.8%
The net result drops to €38,317, the lowest from 2023 to 2025. It recovers the following year.
22-08
NBB filing Annual accounts 2023 filedPDF
micro format · 22 days late
2022
20-12
Gazette deed Incorporation
Starting capital €10,000 · Appointments: VANNESTE Dirk Jozef Maria (director) and LOZIE Anne Marie Louise Yvonne Delphine (director) · Founder13 points ▸
  • Founder, VANNESTE Dirk Jozef Maria
  • Founder, LOZIE Anne Marie Louise Yvonne Delphine
  • Incorporation, “PHARMADIX” (deed in Dutch)
  • Founding capital, €10,000
  • Bank account, “bijzondere rekening geopend namens vennootschap in oprichting”, 06-12-2022 (deed in Dutch)
  • Other provision, “bevestiging deponering overeenkomstig artikel 5:9 Wetboek van Vennootschappen en Verenigingen, artikel 5:9 Wetboek van Vennootschappen en Verenigingen” (deed in Dutch)
  • Share issue, 100, “vergoeding voor de inbrengen” (deed in Dutch)
  • Other provision, “beschikbare eigen vermogensrekening” (deed in Dutch)
  • Pre-incorporation commitments, “takeover, verbintenissen voor rekening en ten name van de vennootschap in oprichting aangegaan” (deed in Dutch)
  • Board rule, 2, “niet-statutaire bestuurders” (deed in Dutch)
  • Director appointment, VANNESTE Dirk Jozef Maria (director (not named in the articles))
  • Director appointment, LOZIE Anne Marie Louise Yvonne Delphine (director (not named in the articles))
  • The act holds 1 more point.

Open the act in the Belgian Official Gazette

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

PHARMADIX was incorporated on 16 December 2022 as a private limited company by two natural persons, with a starting capital of €10,000.12 The board currently has 2 members, 2 of whom have served since 2022.3 Total assets rose from €130,345 in 2023 to €225,469 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 20-12-2022
  3. 3National Bank, annual accounts 2025
  4. 4National Bank, annual accounts 2023 and 2025

Next steps